Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
9
Number of overlapping holdings
13.4%
% of PSCH's 67 holdings also in SBIO
10.0%
% of SBIO's 90 holdings also in PSCH
Overlap by Weight
Sector Drift (PSCH minus SBIO)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSCH |
Weight in SBIO |
Overlap | |
|---|---|---|---|---|
 |
KRYSTAL BIOTECH, INC. | 3.5% | 3.8% | 3.5% |
 |
ALKERMES PLC | 3.4% | 3.3% | 3.3% |
|
CORCEPT THERAPEUTICS INC | 2.3% | 2.5% | 2.3% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.8% | 1.7% | 1.7% |
|
VERICEL CORPORATION | 1.8% | 1.7% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
PSCH Overweight Relative to SBIO
|
ENSIGN GROUP INC/THE | 6.1% |
|
GLAUKOS CORP | 4.8% |
|
ORGANON & CO. | 4.1% |
|
MERIT MEDICAL SYSTEMS INC | 4.0% |
|
RADNET INC | 3.1% |
|
INTEGER HOLDINGS CORPORATION | 3.1% |
|
SELECT MEDICAL HOLDINGS CORP | 2.7% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.7% |
|
ICU MEDICAL INC | 2.4% |
|
CORVEL CORP | 2.1% |
PSCH Underweight Relative to SBIO
|
AVIDITY BIOSCIENCES INC | -2.9% |
|
CRINETICS PHARMACEUTICALS INC | -2.9% |
|
ARCELLX, INC. | -2.5% |
|
DENALI THERAPEUTICS INC. | -2.4% |
|
AMICUS THERAPEUTICS INC | -2.4% |
 |
MERUS N.V. | -2.3% |
|
IDEAYA BIOSCIENCES, INC. | -2.1% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | -2.0% |
|
GERON CORP | -1.9% |
|
ACADIA PHARMACEUTICALS INC | -1.9% |